Brown alga Sargassum muticum inhibits proinflammatory cytokines, iNOS, and COX-2 expression in macrophage RAW 264.7 cells
The present study was designed to elucidate the pharmacological and biological effects of Sargassum muticum extracts on the production of inflammatory mediators in macrophages. S. muticum was extracted with 80% EtOH. The extract was then successively partitioned with n-hexane, CH2Cl2, EtOAc, BuOH, and water. The results indicate that the CH2Cl2 fraction of S. muticum extract was an effective inhibitor of LPS-induced NO and PGE2 production in RAW 264.7 cells. These inhibitory effects of the CH2Cl2 fraction of S. muticum included dose-dependent decreases in the expression of iNOS and COX-2 proteins and iNOS and COX-2 mRNA. To test the inhibitory effects of S. muticum fractions on other cytokines, we also measured IL-1β and IL-6 mRNA expression by RT-PCR in LPS-stimulated RAW 264.7 macrophage cells. In these assays, the CH2Cl2 fraction of S. muticum decreased the expression of IL-1β and IL-6 mRNA in a dose-dependent manner. Based on these results, we suggest that S. muticum extracts may be considered possible anti-inflammatory candidates for human health.
Brown alga Sargassum muticum inhibits proinflammatory cytokines, iNOS, and COX-2 expression in macrophage RAW 264.7 cells
The present study was designed to elucidate the pharmacological and biological effects of Sargassum muticum extracts on the production of inflammatory mediators in macrophages. S. muticum was extracted with 80% EtOH. The extract was then successively partitioned with n-hexane, CH2Cl2, EtOAc, BuOH, and water. The results indicate that the CH2Cl2 fraction of S. muticum extract was an effective inhibitor of LPS-induced NO and PGE2 production in RAW 264.7 cells. These inhibitory effects of the CH2Cl2 fraction of S. muticum included dose-dependent decreases in the expression of iNOS and COX-2 proteins and iNOS and COX-2 mRNA. To test the inhibitory effects of S. muticum fractions on other cytokines, we also measured IL-1β and IL-6 mRNA expression by RT-PCR in LPS-stimulated RAW 264.7 macrophage cells. In these assays, the CH2Cl2 fraction of S. muticum decreased the expression of IL-1β and IL-6 mRNA in a dose-dependent manner. Based on these results, we suggest that S. muticum extracts may be considered possible anti-inflammatory candidates for human health.
___
- 1. Murakami A, Ohigashi H. Targeting NOX, iNOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121: 2357-2363, 2007.
- 2. Vane JR, Mitchell JA, Appleton I et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Pharmacology 91: 2046-2050, 1994.
- 3. Won JH, Im HT, Kim YH et al. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX- 2 expression in RAW 264.7 macrophages via the NF-κB inactivation. Br J Pharmacol 148: 216-225, 2006.
- 4. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350, 1997.
- 5. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109- 142, 1991.
- 6. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls and controls. Cell 78: 915-918, 1994.
- 7. Hinz B, Brune K. Cyclooxygenase-2, 10 years later. J Pharmacol Exp Ther 300: 367-375, 2002.
- 8. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 50; 1535-1542, 1995.
- 9. Needleman P, Isakson PC. Selective inhibition of cyclooxygenase 2. Sci Med 1: 35-36, 1998.
- 10. Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470: 69-78, 2000.
- 11. Tsatsanis C, Androulidaki A, Venihaki M et al. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38: 1654-1661, 2006.
- 12. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-179, 1994.
- 13. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241-246, 2001.
- 4. Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg 80: 289-297, 1993.
- 15. West MA, Li MH, Seatter SC et al. Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J Trauma 37: 82- 89, 1994.
- 16. Stein B, Sutherland MSK. IL-6 as a drug discovery target. Drug Discov Today 3: 202-213, 1998.
- 17. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 8: 253-278, 1990.
- 18. Kim JY, Lee JA, Kim KN et al. Antioxidative and antimicrobial activities of Sargassum muticum extracts. J Korean Soc Food Sci Nutr 36: 663-669, 2007.
- 19. Fernández M, Ríos JC, Jos A et al. Comparative cytotoxicity of alachlor on RTG-2 trout and SH-SY5Y human cells. Arch Environ Contam Toxicol 51: 515-520, 2006
- 20. Kor JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosic Meth 20: 83-89, 2005.
- 21. Hevel JM, Marletta MA. Nitric-oxide synthase assay. Method Enzymol 233: 250-258, 1997.
- 22. Cho JY, Baik KU, Jung JH et al. In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa. Eur J Pharmacol 398: 399-407, 2000.
- 23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
- 24. Dinarello CA. Pro-inflammatory cytokines. Chest 118: 503-508, 2000.